• Overview
• Faculty
• Take Post-Test

Release date: August 15, 2008

Expiration Date: March 1, 2011

Continuing Education Accreditation

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1.5 hours (0.15 CEUs) of continuing education credit. Program number 204-000-08-448-H01P.

This activity is provided free of charge. After participating in the activity, pharmacists may complete the CE test online at the ASHP Learning Center. A passing grade of 70% is required to receive continuing education credit for the activity, and the CE statement can be printed immediately.

Target Audience

This continuing education activity was planned to meet the needs of practitioners, scientists, educators, administrators, and others committed to excellence in clinical pharmacy and patient pharmacotherapy. The program is beneficial for those who treat, instruct, or otherwise participate in the care of ambulatory and hospitalized patients with or at risk for venous thromboembolism.

Activity Content

Click here to view an overview of the activity content.

Learning Objectives

After participating in this knowledge-based educational activity, participants should be able to

• Describe the clinical and economic burden, pathophysiology, clinical presentation, and diagnosis of VTE, and list common risk factors for VTE.
• Compare and contrast the pharmacology, monitoring requirements, and role of various anticoagulant agents in patients with or at risk for VTE.
• Assess the risk for VTE in both a hospitalized patient with acute medical illness and a surgical patient and recommend appropriate prophylactic anticoagulant therapy.
• Recommend appropriate anticoagulant therapy and monitoring parameters for a patient with VTE.
• Explain the rationale for ACCP guidelines for anticoagulant therapy in patients with or at risk for VTE based on the results of key clinical trials.
• Identify at least one performance measure that can be applied in the practice setting to improve care for patients at risk for VTE.

Faculty

Katherine W. Phillips, Pharm.D., CACP
Clinical Specialist – Cardiology/ Anticoagulation
Boston Medical Center
Boston, Massachusetts

Faculty Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education's and the Accreditation Council for Pharmacy Education's Standards for Commercial Support, ASHP requires that all individuals involved in the development of program content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.

The faculty and planners report the following relationships:

Katherine W. Phillips, Pharm.D., CACP
Dr. Phillips declares that she has no relationships pertinent to this activity.

Cathy C. Bowles, R.Ph.
Ms. Bowles declares that she has no relationships pertinent to this activity.

Susan R. Dombrowski, M.S., R.Ph.
Ms. Dombrowski declares that she has no relationships pertinent to this activity.

Planned and conducted by ASHP Advantage and
supported by an educational grant from sanofi-aventis U.S.

Launch Presentation*

Applying Evidence-Based Guidelines for Anticoagulant Therapy in the Prevention and Treatment of Venous Thromboembolism (85 minutes)
Katherine W. Phillips, Pharm.D., CACP

*Allow additional time to complete the post-test and evaluation.

Download Post-Test

Click here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Advantage Testing Center and complete the test online.